Consistently and as in NSCLC lymph nodes, very low percentages of ICOS-L+ naïve and transitional pre-GC IgD+ B cells were observed in tumors compared with NSCLC patient blood samples (Supplementary Figure 6A, lower panels). The gene discussed is ICOSLG; the disease is non-small cell lung carcinoma.